<!doctype html><html lang=cn><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta name=referrer content="no-referrer"><link rel=dns-prefetch href=https://i.geekbank.cf/><title>首个国产长效GLP-1激动剂上市 2型糖尿病患者治疗有新选择 | 极客快訊</title><meta property="og:title" content="首个国产长效GLP-1激动剂上市 2型糖尿病患者治疗有新选择 - 极客快訊"><meta property="og:type" content="article"><meta property="og:locale" content="cn"><meta property="og:image" content="https://p1.pstatp.com/large/pgc-image/71e6bf400f9b4c3aa82843a1f303616b"><link rel=alternate hreflang=x-default href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=alternate hreflang=zh-tw href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=alternate hreflang=zh-cn href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=alternate hreflang=zh-hk href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=alternate hreflang=zh-mo href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=alternate hreflang=zh-my href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=alternate hreflang=zh-sg href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/70f6c80.html><link rel=canonical href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/70f6c80.html><meta property="article:published_time" content="2020-10-29T20:57:50+08:00"><meta property="article:modified_time" content="2020-10-29T20:57:50+08:00"><meta name=Keywords content><meta name=description content="首个国产长效GLP-1激动剂上市 2型糖尿病患者治疗有新选择"><meta name=author content="极客快訊"><meta property="og:url" content="/cn/%E7%A7%91%E5%AD%A6/70f6c80.html"><link rel=apple-touch-icon sizes=180x180 href=../../apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=../../favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=../../favicon-16x16.png><link rel=manifest href=../../site.webmanifest><link rel=mask-icon href=../../safari-pinned-tab.svg color=#5bbad5><meta name=msapplication-TileColor content="#ffc40d"><meta name=theme-color content="#ffffff"><link rel=stylesheet href=https://geekbank.cf/css/normalize.css><link rel=stylesheet href=https://geekbank.cf/css/style.css><script type=text/javascript src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js></script><script type=text/javascript src=https://geekbank.cf/js/jqthumb.min.js></script><script data-ad-client=ca-pub-3525055026201463 async src=https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js></script></head><body><header id=header class=clearfix><div class=container><div class=col-group><div class=site-name><h1><a id=logo href>🤓 极客快讯 Geek Bank</a></h1><p class=description>为你带来最全的科技知识 🧡</p></div><div><nav id=nav-menu class=clearfix><a class=current href>猜你喜歡</a>
<a href=../../tw/categories/%E7%A7%91%E6%8A%80.html title=科技>科技</a>
<a href=../../tw/categories/%E9%81%8A%E6%88%B2.html title=遊戲>遊戲</a>
<a href=../../tw/categories/%E7%A7%91%E5%AD%B8.html title=科學>科學</a></nav></div></div></div></header><div id=body><div class=container><div class=col-group><div class=col-8 id=main><div class=res-cons><article class=post><header><h1 class=post-title>首个国产长效GLP-1激动剂上市 2型糖尿病患者治疗有新选择</h1></header><date class="post-meta meta-date">2020-10-29</date><div class=post-meta><span>|</span>
<span class=meta-category><a href=cn/categories/%E7%A7%91%E5%AD%A6.html>科学</a></span></div><div class=post-content><div><p>近日，国家药监局发布消息称，1类创新药物聚乙二醇洛塞那肽注射液，已由该局通过优先审评审批程序批准上市，用于改善成人2型糖尿病患者的血糖控制。聚乙二醇洛塞那肽是长效GLP-1受体激动剂，可促进葡萄糖依赖的胰岛素分泌，配合饮食控制和运动，单药或与二甲双胍联合，用于改善成人2型糖尿病患者的血糖控制，该药的上市将为2型糖尿病患者提供新的治疗选择。</p><div class=pgc-img><img alt="首个国产长效GLP-1激动剂上市 2型糖尿病患者治疗有新选择" onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/71e6bf400f9b4c3aa82843a1f303616b><p class=pgc-img-caption></p></div><p>GLP-1是人体胃肠道黏膜天然分泌的一种“肠促胰素”，可与胰岛细胞上的受体结合并刺激胰岛素分泌，进而产生降低血糖的作用；2型糖尿病患者的GLP-1分泌明显减少。但GLP-1在体内易被降解，需通过持续静脉滴注或持续皮下注射产生疗效；GLP-1受体激动剂为其同源性物质，不易发生降解，且与受体的亲和力强。</p><p>研究发现，此类降糖药的低血糖事件发生率明显低于胰岛素，可减少食物摄取和延缓胃排空，有利于患者控制体重，还可保护胰岛β细胞功能。部分GLP-1受体激动剂类药物，还被证实具有心血管益处。GLP-1受体激动剂已成为糖尿病治疗领域近年来最具增长潜力的一类降糖药物。</p><p>GLP-1受体激动剂类降糖药分为短效和长效两类。据记者查询统计，目前国内获批上市的短效GLP-1受体激动剂共有3种，分别需要每日注射1次～3次；每周注射1次的长效GLP-1受体激动剂有2种，且均为进口产品。（来源 健康报 首席记者 刘志勇）</p><div class=pgc-img><img alt="首个国产长效GLP-1激动剂上市 2型糖尿病患者治疗有新选择" onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/0a3acf7fff644af1b70a56bc1401511c><p class=pgc-img-caption></p></div></div></div><div class="post-meta meta-tags"><ul class=clearfix><li><a>'首个','国产长','GLP'</a></li></ul></div></article></div></div><div id=secondary><section class=widget><form id=search action=//www.google.com/search method=get accept-charset=utf-8 target=_blank _lpchecked=1><input type=text name=q maxlength=20 placeholder=搜索>
<input type=hidden name=sitesearch value=geekbank.cf>
<button type=submit>🔍</button></form></section><section class=widget><h3 class=widget-title>最新文章 ⚡</h3><ul class=widget-list></ul></section><section class=widget><h3 class=widget-title>其他</h3><ul class=widget-list><li><a href=TOS.html>使用條款</a></li><li><a href=CommentPolicy.html>留言政策</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>DMCA</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>聯絡我們</a></li></ul></section></div></div></div></div><footer id=footer><div class=container>&copy; 2020 <a href>极客快訊</a></div></footer><script type=text/javascript>window.MathJax={tex2jax:{inlineMath:[['$','$']],processEscapes:true}};</script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML" async></script><a id=rocket href=#top></a><script type=text/javascript src=https://kknews.cf/js/totop.js async></script><script type=application/javascript>var doNotTrack=false;if(!doNotTrack){window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;ga('create','UA-146415161-2','auto');ga('send','pageview');}</script><script async src=https://www.google-analytics.com/analytics.js></script><script type=text/javascript src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5e508ed9e4e698bb"></script></body></html>